Registry of Lobbyists

Rapport mensuel de communication

Retour au Registration for Teva Canada Limited / Teva Canada Limitee

5088-606104

Entreprise : GlaxoSmithKline
Enregistrement connexe : 953603-5088-64
Date de la communication : 2024-06-04
Date de publication : 2024-07-15

Titulaires d'une charge publique désignée ayant participé à la communication : Rodrigo Arancibia, Director
Life Science Industries Directorate, Innovation, Sciences et Développement économique Canada (ISDE)

Jocelyn  Milburn, Director
Office of Life Sciences and Biomanufacturing Readiness, Innovation, Sciences et Développement économique Canada (ISDE)

Caroline Menard, Manager
Innovation, Sciences et Développement économique Canada (ISDE)

Ritu Banerjee, Assistant Deputy Minister
Director General's Office, Innovation, Sciences et Développement économique Canada (ISDE)
 
Subject Matter of the communication: Développement économique,  Santé
 
Responsible Officer who filed this communication report: Sridhar Venkatesh
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Return to Registration for Teva Canada Limited / Teva Canada Limitee
Date Modified: